BIOCARTIS news, videos and press releases - Page 4
For more news please use our advanced search feature.
BIOCARTIS - More news...
BIOCARTIS - More news...
- Press release Biocartis NV: Invitation to the Special Shareholders’ Meeting
- Biocartis Group NV: Biocartis and Kite Sign Agreement for Development of Assays supporting Kite's Therapies
- Biocartis Group NV: Disclosure of transparency notifications
- Biocartis Group NV: Disclosure of a transparency notification
- Biocartis Group NV: Idylla(TM) MSI Performance Study Selected for Publication at ASCO Conference
- Biocartis Group NV: Results of the annual shareholders' meeting held on 10 May 2019
- Biocartis Group NV: BIOCARTIS ANNOUNCES FINAL TERMS OF ITS EUR 150 MILLION SENIOR UNSECURED CONVERTIBLE BONDS DUE 9 MAY 2024
- Biocartis Group NV: BIOCARTIS ANNOUNCES SUCCESSFUL PLACEMENT OF EUR 150 MILLION SENIOR UNSECURED CONVERTIBLE BONDS DUE 9 MAY 2024
- Biocartis Group NV: BIOCARTIS LAUNCHES CONVERTIBLE BONDS OFFERING OF EUR 125 MILLION
- Biocartis Group NV: BIOCARTIS Q1 2019 BUSINESS UPDATE
- Biocartis Group NV: Biocartis Announces Global Collaboration with Covance
- Biocartis Group NV: Invitation to Annual Shareholders' Meeting
- Biocartis Group NV: Invitation to Annual Shareholders' Meeting
- Biocartis Group NV: DISCLOSURE OF OUTSTANDING VOTING SECURITIES
- Biocartis Group NV: DISCLOSURE OF OUTSTANDING VOTING SECURITIES
- Biocartis Group NV: Biocartis announces publication of its 2018 annual report
- Biocartis Group NV: Biocartis announces publication of its 2018 annual report
- Biocartis Group NV: Biocartis announces CE-IVD marking of its Idylla(TM) MSI Test
- Biocartis Group NV: BIOCARTIS ANNOUNCES 2018 RESULTS AND 2019 OUTLOOK
- Biocartis Group NV: Biocartis Places Its 1,000th Idylla(TM) Instrument with Geisinger in US
- Biocartis Group NV: BIOCARTIS TO HOST WEBCAST FOR ANNOUNCEMENT 2018 FINANCIAL RESULTS ON 28 FEBRUARY 2019
- Biocartis Group NV: Disclosure of a transparency notification
- Biocartis Group NV: DISCLOSURE OF OUTSTANDING VOTING SECURITIES
- Biocartis Group NV: Disclosure of a transparency notification
- Biocartis Group NV: BIOCARTIS SUCCESSFULLY RAISES EUR 55.50 MILLION
- Biocartis Group NV: BIOCARTIS UPSIZES ITS EQUITY PLACEMENT DUE TO SIGNIFICANT DEMAND
- Biocartis Group NV: BIOCARTIS LAUNCHES EQUITY PLACEMENT
- Biocartis Group NV: Biocartis Announces Achieving its 2018 Key Business Objectives
- Biocartis Group NV: Biocartis Announces Achieving its 2018 Key Business Objectives
- Biocartis Group NV: Biocartis and Nichirei Bioscience Announce Commercialization Collaboration for Japanese Market
